Skip Navigation
Skip to contents




17 results

Valproate Induced Hair Loss and Curly Hair in Bipolar Disorder

Uygur OF, Uygur H

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):566-567.
  • doi: 10.9758/cpn.2019.17.4.566
No abstract available.
Letter: A Comment on “Successful Management of Clozapine-induced Akathisia with Gabapentin Enacarbil: A Case Report”

Naguy A

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):564-565.
  • doi: 10.9758/cpn.2019.17.4.564
No abstract available.
Efficacy of Asenapine in Schizophrenia Resistant to Clozapine Combined with Electroconvulsive Therapy: A Case Report

Ochi S, Inoue S, Yoshino Y, Shimizu H, Iga JI, Ueno SI

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):559-563.
  • doi: 10.9758/cpn.2019.17.4.559
Schizophrenic patients resistant to antipsychotics are diagnosed as having treatment-refractory schizophrenia, and they are treated with clozapine. However, clozapine is sometimes combined with electroconvulsive therapy (ECT) if clozapine monotherapy fails....
Hypertension Induced by Aripiprazole Use in an Autistic Child Patient

Uzun AD, Sapmaz SY, Öztürk M, Kandemir H

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):556-558.
  • doi: 10.9758/cpn.2019.17.4.556
Atypical antipsychotics in children and adolescents are widely used for aggression, emotional variability and psychosis treatment. Aripiprazole is also an atypical antipsychotic that increasingly used in children and adolescents with...
Aripiprazole-induced Hepatitis: A Case Report

Castanheira L, Fernandes , Levy P, Coentre R

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):551-555.
  • doi: 10.9758/cpn.2019.17.4.551
Aripiprazole is an atypical antipsychotic that acts as a partial agonist of dopamine type 2 receptors as well as 5-HT1A receptors. It is used in the treatment of schizophrenia and...
Effect of Suvorexant on Nocturnal Delirium in Elderly Patients with Alzheimer's Disease: A Case-series Study

Hanazawa T, Kamijo Y

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):547-550.
  • doi: 10.9758/cpn.2019.17.4.547
Suvorexant, an orexin receptor antagonist used for insomnia, has been shown to have a preventive effect on delirium in a randomized placebo-controlled trial. However, its effectiveness in the management of...
The Effect of a Sleep Education and Hypnotics Reduction Program on Hypnotics Prescription Rate for the Hospitalized Patients with Cancer at a General Hospital

Youn S, Lee S, Kim C, Chung S

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):542-546.
  • doi: 10.9758/cpn.2019.17.4.542
OBJECTIVE: We aimed to investigate whether the sleep education and hypnotics reduction program (the i-sleep program), developed for all hospitalized patients and medical personnel, help reducing the hypnotics prescriptions rate...
Effectiveness and Safety of Bupropion in Children and Adolescents with Depressive Disorders: A Retrospective Chart Review

Kweon K, Kim HW

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):537-541.
  • doi: 10.9758/cpn.2019.17.4.537
OBJECTIVE: This study aimed to investigate the effectiveness and safety of bupropion extended-release for the treatment of depressive disorder in children and adolescents. METHODS: This was a 12-week, retrospective chart review...
The Impact of Paliperidone Palmitate on Hospitalization in Patients with Schizophrenia: A Retrospective Mirror-image Study

Oh SY, Jon DI, Hong HJ, Hong N, Yi JS, Roh D, Jung MH

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):531-536.
  • doi: 10.9758/cpn.2019.17.4.531
OBJECTIVE: Whether long-acting injectable antipsychotics (LAI) are superior to oral antipsychotics remains a controversial question, and results vary depending on the study design. Our study was performed to compare outcomes...
Can Propofol Lead to an Increase in Seizure Threshold Over the Course of Electroconvulsive Therapy?

Aytuluk HG, Simsek T, Yilmaz M, Turan AZ, Saracoglu

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):523-530.
  • doi: 10.9758/cpn.2019.17.4.523
OBJECTIVE: To evaluate the effects of 2 different dose regimens of propofol (low dose: < 1 mg/kg, high dose: ≥ 1 mg/kg) on the duration of the seizures, the required...
Determination of Serum Vascular Endothelial Growth Factor Levels in Attention Deficit Hyperactivity Disorder: A Case Control Study

Torun YT, Güney E, Aral A, Büyüktaşkin D, Tunca H, Taner YI, İşeri E

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):517-522.
  • doi: 10.9758/cpn.2019.17.4.517
OBJECTIVE: The effect of vascular endothelial growth factor (VEGF) on neuronal development is known, but its relationship with attention deficit hyperactivity disorder (ADHD), a neurodevelopmental disorder, has not yet been...
Altered Auditory P300 Performance in Parents with Attention Deficit Hyperactivity Disorder Offspring

Chi MH, Chu CL, Lee IH, Hsieh YT, Chen KC, Chen PS, Yang YK

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):509-516.
  • doi: 10.9758/cpn.2019.17.4.509
OBJECTIVE: Altered event-related potential (ERP) performances have been noted in attention deficit hyperactivity disorder (ADHD) patients and reflect neurocognitive dysfunction. Whether these ERP alterations and correlated dysfunctions exist in healthy...
Difference in Cognitive Function by First Onset Age of Alcohol Induced Blackout and Its Duration

Min EJ, Kim SG, Lee JS, Seo B, Jung WY, Huh SY, Park JH, Hong CH, Yu HJ

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):503-508.
  • doi: 10.9758/cpn.2019.17.4.503
OBJECTIVE: Alcohol-induced blackout (blackout) is a typical early symptom of cognitive impairment caused by drinking. However, the first onset age of blackout or the duration after onset of blackout has...
The Potential Utility of Aripiprazole Augmentation for Major Depressive Disorder with Mixed Features Specifier: A Retrospective Study

Han C, Wang SM, Bahk WM, Lee SJ, Patkar AA, Masand PS, Pae CU

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):495-502.
  • doi: 10.9758/cpn.2019.17.4.495
OBJECTIVE: The present study aimed to observe potential benefit of aripiprazole augmentation in the treatment of major depressive disorder with mixed specifier (MDDM) in naturalistic treatment setting. METHODS: Data were collected...
The Interaction of Oxytocin and Social Support, Loneliness, and Cortisol Level in Major Depression

Tsai TY, Tseng HH, Chi MH, Chang HH, Wu CK, Yang YK, Chen PS

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):487-494.
  • doi: 10.9758/cpn.2019.17.4.487
OBJECTIVE: Loneliness is a specific risk factor for depressive symptoms and suicidal behavior. The present study examined whether the serum oxytocin level would interact with social support and buffers loneliness...
Biological Aspects of Aggression and Violence in Schizophrenia

Cho W, Shin WS, An I, Bang M, Cho DY, Lee SH

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):475-486.
  • doi: 10.9758/cpn.2019.17.4.475
Although the majority of patients with schizophrenia are not actually violent, an increased tendency toward violent behaviors is known to be associated with schizophrenia. There are several factors to consider...
Heart and Brain Interaction of Psychiatric Illness: A Review Focused on Heart Rate Variability, Cognitive Function, and Quantitative Electroencephalography

Jung W, Jang KI, Lee SH

  • Clin Psychopharmacol Neurosci.
  • 2019 Nov;17(4):459-474.
  • doi: 10.9758/cpn.2019.17.4.459
Heart rate variability (HRV) reflects beat-to-beat variability in the heart rate due to the dynamic interplay of the sympathetic and parasympathetic nervous systems. HRV is considered an index of the...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: